rancis Medical, Inc., a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney and bladder cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its Vanquish minimally invasive water vapor ablation therapy.
Memorial Sloan Kettering Cancer Center has been recognized as the best cancer center in the northeast, the number two hospital for cancer care in the nation, and the number one hospital nationally for urology care by U.S. News & World Report in its annual Best Hospitals listing.
Hyung L. Kim, MD, a leading urologic oncologist, skilled surgeon and accomplished researcher frequently funded by the National Institutes of Health, was recently selected to be the inaugural chair of the Department of Urology at Cedars-Sinai.
The United States Senate unanimously passed the Securing the U.S. Organ Procurement Transplantation Network (OPTN) Act (S. 1668), following House passage earlier this week, marking a new era for the United States transplant system.
According to the National Kidney Foundation, more than 100,000 Americans are waiting for a kidney transplant, and the demand for donated kidneys far exceeds the supply. In fact, only 25,498 kidney transplants were performed in 2022, and kidney disease impacts 37 million people in the U.S. But a new preclinical study, led by scientists at Wake Forest University School of Medicine, shows that a new technology called mitochondrial transplantation holds promise as a potential therapy that could change the kidney transplant landscape.
The American Society of Nephrology (ASN) celebrates the unanimous passage of the Securing the U.S. Organ Procurement Transplantation Network (OPTN) Act (H.R. 2544) by the United States House of Representatives. This bipartisan legislation will increase transparency, accountability, and competition in the U.S. transplant system.
The Hypertension Center in the Smidt Heart Institute at Cedars-Sinai has earned accreditation from the American Heart Association, signifying that it exceeds the highest standards of care for patients with high blood pressure—a condition that affects nearly half of all U.S. adults and increases risk for heart attack, stroke and kidney failure.
Not for public release
This news release is embargoed until 24-Jul-2023 5:00 PM EDT
Released to reporters: 18-Jul-2023 2:00 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 24-Jul-2023 5:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Valance Sams Sr.’s world was turned upside down 10 years ago when he was diagnosed with sarcoidosis, a rare inflammatory disease that caused a buildup of scar tissue on his heart and left him unable to work, exercise or even walk.
Based on findings from a study published today in the journal, The Lancet Regional Health – Americas, researchers at Johns Hopkins Medicine and three collaborating medical institutions suggest that people living with the human immunodeficiency virus (HIV) who donate a kidney to other people living with HIV (PLWH) have a low risk of developing end-stage kidney disease (ESKD) or other kidney problems in the years following the donation.
Long-term circadian disruption in a rat model of high blood pressure accelerated stroke onset and shortened lifespan, according to researchers from Morehouse School of Medicine in Atlanta.
In the next step toward producing the answer to kidney transplantation shortages, Dr. Anthony Atala, Director of the Wake Forest Institute for Regenerative Medicine (WFIRM), and the kidney research team, have been awarded the prestigious KidneyX Track 2 $1 Million Prize for work based on a 3D kidney construct platform.
Francis Medical, Inc., a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney, and bladder cancer, today announced the first patient has been treated in the company's VAPOR 2 pivotal clinical study evaluating the safety and efficacy of its Vanquish minimally invasive water vapor ablation therapy for managing prostate cancer.
Ochsner Health announced today that it has become the first healthcare organization in Louisiana to offer Aquablation therapy for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (BPH).
Approximately 90,000 Americans, including 1,100 children are currently waiting for a kidney transplant. Tragically, 12 Americans will die today waiting for a kidney. Advocates from the American Society of Nephrology (ASN) are on Capitol Hill today urging Congress to implement reforms that will help maximize access to transplant care for the 37 million Americans living with kidney diseases; the 8th leading cause of death in the United States.
Urotronic, Inc., a Minnesota-based medical device company pioneering the application of its drug-coated balloon technologies for use in interventional urology, today announced the world's first commercial procedure of the Optilume BPH® Catheter System to treat benign prostatic hyperplasia (BPH) was completed by Dr. Dean Elterman, urologist at University Urology Associates, in Toronto, Canada.
Fiscal year 2023, which ended June 30, proved to be the busiest year yet for Cedars-Sinai’s Comprehensive Transplant Center and Smidt Heart Institute, with more than 600 organs transplanted.
Patients who engage in light exercise while undergoing dialysis are physically fitter and are admitted to hospital less frequently than those who do not.
Researchers at the UCLA Jonsson Comprehensive Cancer Center have confirmed that a large number of genetic variants of unknown significance are in fact verified mutations that predispose patients to a rare hereditary syndrome that increases the risk of kidney cancer.
When an ill person schedules a doctor visit, blood work or other diagnostic testing is often required before a diagnosis is determined. Missouri University of Science and Technology electrical engineering researcher Dr. Jie Huang is developing technology that would allow patients to “just breathe” and avoid that testing.
Not for public release
This news release is embargoed until 10-Jul-2023 5:00 PM EDT
Released to reporters: 5-Jul-2023 2:00 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 10-Jul-2023 5:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Prof. Pol.Capt. Pharm. Dr. Suchada Sukrong, lecturer at the Faculty of Pharmaceutical Sciences and a researcher at the Center of Excellence in DNA Barcoding of Thai Medicinal Plants, Chulalongkorn University, Dr. Kannika Thongkhao, and Pharm. Chayaphol Tangpatthong have won the gold medal and two Special Awards, namely the FIRI Award in the Best Invention category from “The first institute of inventors and researchers of Iran” (FIRI), Iran, and a Special Awards from “The Industrial Property Office of the Czech Republic the Czech Metallurgical Society,” The Czech Republic, in The 16th International Invention and Innovation Show (INTARG 2023) on May 24-25, 2023, at Katowice International Conference Center, Katowice, Republic of Poland, with their “Rapid DNA immunochromatographic assay for detection of toxic Aristolochia species, the plants responsible for aristolochic acid nephropathy”.
In a study led by Johns Hopkins Medicine, in collaboration with Yale School of Medicine, researchers have identified a biomarker found via a simple urine test that can be used to diagnose acute tubulointerstitial nephritis (AIN), a medical condition that causes inflammation of the kidneys and can lead to acute kidney injury (AKI) — a sudden loss of kidney function. Experts say a kidney biopsy is often required to diagnose AIN because there are no disease-specific signs or symptoms.
KidneyCure (the ASN Foundation) is honored to continue its support of investigators committed to advancing kidney health. Building on decades of success, KidneyCure makes it possible to improve knowledge and treatment by identifying and funding high-impact projects. Investigators funded by KidneyCure are making a difference in key areas that impact care for millions. KidneyCure is proud to support excellence and innovation, and to extend the advances that the foundation has propelled since its inception.
A new study finds that the minimum level of oxygen delivery during cardiopulmonary bypass may be lower than previously thought — meaning, there may be opportunities to avoid transfusing patients during cardiac surgical procedures. Researchers say cardiac surgical programs may be unnecessarily transfusing patients to prevent kidney injury.
Today, AACC—in collaboration with the National Kidney Foundation (NKF)—released guidance to reduce racial and gender disparities in the care of patients with chronic kidney disease (CKD). The document gives members of the healthcare team actionable, evidence-based tools to improve equity in kidney health, including recommendations for using an updated algorithm that does not disproportionately affect any one group of individuals.
Researchers at The University of Texas MD Anderson Cancer have engineered a new model of aggressive renal cell carcinoma (RCC), highlighting molecular targets and genomic events that trigger chromosomal instability and drive metastatic progression.
The study, published today in Nature Cancer, demonstrates that the loss of a cluster of interferon receptor (IFNR) genes plays a pivotal role in allowing cancer cells to become tolerant of chromosomal instability. This genomic feature may be used to help clinicians predict a tumor’s potential to become metastatic and treatment resistant.
Renal cell carcinoma is the most common form of kidney cancer. To treat metastatic renal cancer, combinations of immunotherapies are used as the first line of treatment.
Loyola Medicine's advanced robotic surgery program makes it one of the few hospitals in the country to offer kidney transplantation to patients with obesity.
Mortality in patients with kidney failure has been found to be 23% lower among those treated with high dose haemodiafiltration compared to those treated with high flux haemodialysis, according to new research from the CONVINCE consortium led by University Medical Center Utrecht.
The painful experience of having a kidney stone has become more common in recent years, including in Texas, part of the “Stone Belt” where hot weather can cause dehydration. But small dietary changes as well as drinking lots of water can help avert the discomfort, says a board-certified physician assistant in the Department of Urology at UT Southwestern Medical Center.
Today, the Kidney Innovation Accelerator (KidneyX), a public private partnership between the American Society of Nephrology (ASN) and the US Department of Health and Human Services (HHS) announced the eight winners of the Artificial Kidney Prize Phase 2 at the KidneyX Summit in Washington, DC. The competition recognized participants’ innovative approaches to developing a bioartificial kidney and was divided into two tracks with two Track 1 participants each receiving $1,600,000, and six Track 2 participants each receiving $1,000,000.
Fatigue is the symptom that most significantly impacts the daily lives of long Covid patients, and can affect quality of life more than some cancers, finds a new study led by researchers at UCL and the University of Exeter.
Some centers routinely skip the top kidney transplant candidates on the wait list and give the kidney to lower-ranked patients, finds a new study at Columbia University.
La insuficiencia renal puede tener diversas causas: diabetes, presión arterial alta, enfermedades autoinmunitarias y enfermedad renal poliquística o ERP.
Cedars-Sinai clinicians and scientists, including Medawar Prize winner Stanley Jordan, MD, and prominent nephrology and immunology investigator Peter Heeger, MD, will share their latest advances in research at the American Transplant Congress (ATC), June 3-7, 2023, in San Diego.
Researchers found that receiving intensive antihypertensive treatment as an inpatient was linked with greater risk of adverse events, particularly for patients receiving the medication intravenously as opposed to orally.
Each year, ASN recognizes individuals who have demonstrated exceptional leadership and achievements in clinical care, education, and research through our lifetime achievement and midcareer awards. Above all, kidney professionals imbue their work with compassion, dedication, and respect for the people whose lives they improve.
The American Society of Nephrology (ASN) announced today that Rajnish Mehrotra, MD, MS, FASN, will be its new Editor-in-Chief of the Journal of the American Society of Nephrology (JASN) and Senior Editor-in-Chief for the ASN Journal Portfolio. Mehrotra’s term will begin January 1, 2024, and continue through December 31, 2029. He currently serves as the Editor-in-Chief of CJASN. The ASN Journal Portfolio includes three monthly journals, JASN, CJASN, and the online-only, open access journal, Kidney360.
Announcement of Zoe Stewart Lewis, MD, PhD, MPH, as the new Director of Cleveland's University Hospitals Transplant Institute and Chief of the Division of Transplant and Hepatobiliary Surgery in the Department of Surgery.
20240208171546.png&width=400&height=400)
RSS